Armodafinil waklert is the name of the armodafinil-containing Waklert tablets, in which the armodafinil 150 mg dosage strength is referred to as Waklert 150. Armodafinil is a wakefulness-promoting drug acting on the central nervous system and used to enhance wakefulness in association with certain sleep disorders. According to the Australian medicines information, armodafinil is indicated for excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnoea/hypopnoea syndrome (OSAHS), and chronic shift work sleep disorder (SWSD). Armodafinil does not treat the underlying airway obstruction but alleviates excessive sleepiness in OSAHS and is therefore referred to as an adjunct to adequate CPAP treatment.
The dose of armodafinil for narcolepsy and OSAHS is recommended to be 150 mg or 250 mg once daily in the morning, whereas for SWSD – 150 mg about one hour before the work shift. Armodafinil is registered in Australia as prescription-only Schedule 4 medicine. Therefore, Waklert 150 means armodafinil 150 mg tablets, whereas its use is associated with improving wakefulness in these specific sleep disorders.
https://www.genericmedsaustralia.com.au/products/waklert-150-australia/
Armodafinil Waklert 150 mg is a prescription wakefulness-promoting medicine used to help improve wakefulness in adults with excessive sleepiness associated with conditions such as narcolepsy, obstructive sleep apnea, or shift work disorder. Its use should follow medical guidance, including appropriate dosing, precautions, potential side effects, and consideration of individual health needs.
